Cannabis Evolving Opportunity in an Emerging Industry - Cassels Brock
←
→
Page content transcription
If your browser does not render page correctly, please read the page content below
Cannabis Evolving Opportunity in an Emerging Industry When a new industry is being formed, it is critical to be assisted by an entrepreneurial and experienced firm. Cassels Brock is able to offer the services required to help your company invest and grow into a major player in the cannabis industry. Cassels Brock has distinguished itself at the forefront of the cannabis industry, providing a wide range of expertise in connection with corporate, securities, regulatory, intellectual property, financing, real estate, municipal zoning & by-law and employment matters. We act as corporate and securities counsel for various private and public companies in the cannabis industry. We act for licensed producers and late stage applicants on various matters including licensing, financings, M&A, and go-public transactions. We have also worked with many ancillary players in the cannabis space including private equity, technology, branding, research, and pharmacology companies. In addition to the foregoing, the firm has acted in the capacity of underwriters’ counsel on numerous equity and debt financings and public offerings completed for cannabis companies. Our lawyers are renowned not only for their exceptional proficiency in corporate finance, securities matters and M&A, but also for their contributions to thought leadership in connection with financing, structuring and regulatory issues and work with prominent business and political leaders on groundbreaking industry matters. We are frequently called upon to write and speak on advancements and innovation in the industry. Our lawyers have been called upon as expert presenters on marketing and branding, investing, cross-border and intellectual property matters at various cannabis industry conferences including O’Cannabiz Conference & Expo, Lift Business Conference & Expo, National Cannabis Bar Association’s Cannabis Law Institute, GrowUp Conference & Expo and the CLFA Annual Conference. Some of our experience involving clients in the cannabis industry includes: Company Cassels Brock Role Canopy Growth Corporation (TSX: WEED; Advised on its listing on the New York Stock Exchange NYSE: CGC) Acted on its $600 million offering, the largest financing in the cannabis The world’s largest publicly traded cannabis industry to date company; first federally regulated, publicly Acting on its acquisition of Hiku Brands Company Ltd. traded cannabis producer in North America; Toronto Stock Exchange and New York Stock Acted on its $375 million acquisition of remaining 33% of BC Tweed Joint Exchange listed company Ventures Inc. Advised on the launch of its Latin American subsidiary Canopy LATAM and acquisition of Spectrum Cannabis Colombia S.A.S and Canindica Capital Ltd. Acted on a collaborative international joint venture with Green House Holdings North America and National Concessions Group Inc. Acted on the acquisition of Annabis Medical, s.r.o., the largest medical cannabis company in the Czech Republic Acted on its expansion into New Brunswick, including the acquisition of Spot Therapeutics Inc. Acted, alongside Canopy Rivers Corporation and funds managed by JW Asset Management LLC, on a strategic investment in TerrAscend Corp. Current as of August 2018
Company Cassels Brock Role Canopy Growth Corporation (continued) Acting on a joint venture to create Les Serres Vert Cannabis Inc. and convert up to 700,000 square feet of existing greenhouse space in Québec Advising on intellectual property aspects of collaboration with Great Gardeners Farms, including brand and genetics licences Acting on various corporate, commercial, real estate, regulatory, securities and intellectual property licensing matters MedMen Enterprises Inc. (MMEN) Acted on its listing on the Canadian Securities Exchange Canadian Securities Exchange listed company Advised in connection with its collaborative cross border joint venture with whose operations in the United States account for Cronos Group Inc. to form MedMen Canada nearly half of North America’s legal cannabis market Acted in connection with a US$110 million private placement Canopy Rivers Corporation Acting on Canopy Rivers go-public transaction The cannabis industry’s first strategic support Acted on a $104 million, $36.2 million and $26 million private placement for platform providing growth capital and strategic Canopy Rivers, including the first cannabis transaction involving CIBC Capital support to selected licensed producers and Markets licensed producer applicants Acted, alongside Canopy Growth Corporation and funds managed by JW Asset Management LLC, on a strategic investment in TerrAscend Corp. Acted on an investment in Agripharm Corp. for up to $20 million in exchange for royalty payments and warrants Acted on various investments, including Civilized Worldwide Inc., James E. Wagner Cultivation Corporation and LiveWell Canada Inc. Acting on various corporate, commercial, financial services, securities and intellectual property matters Bedrocan Cannabis Corp. Counsel to POCML 2 Inc. in connection with its reverse takeover of Bedrocan Cannabis Corp. One of the first two companies to supply pharmaceutical-grade medicinal cannabis in Counsel in its acquisition by Canopy Growth Corporation (formerly Tweed Canada and the second publicly listed medical Marijuana Inc.) via plan of arrangement cannabis producer in Canada BC Tweed Joint Venture Inc. Acted on the formation of BC Tweed A joint venture between Canopy Growth and Acted on a joint venture to create BC Tweed Joint Venture Inc. and convert up an established greenhouse grower with over to 3 million square feet of existing greenhouse in British Columbia 1,740,000 square feet of currently licensed Counsel on various corporate and financing matters growing space at two facilities, one of which is the largest cannabis facility in the world Green Thumb Industries Inc. (GTII) Acting on its $80.3 million bought deal financing Canadian Securities Exchange listed company Acted on its listing on the Canadian Securities Exchange that is a multi-state cannabis cultivator, Acted in connection with an $87 million subscription receipt financing in processor and dispensary operator connection with its listing on the Canadian Securities Exchange CannaRoyalty Corp. (CRZ) Counsel on various corporate, securities and other matters Canadian Securities Exchange listed company Acted in connection with its going-public reverse takeover transaction as well which has acquired a diversified portfolio of as a $15 million bought deal offering cannabis industry investments Acted on a $17.25 million bought deal prospectus offering of units Acting in connection with a $12 million revolving secured credit facility with Sprott Canna Holdco Corp., expected to be used for specific opportunities to be pursued by CannaRoyalty with respect to production and processing assets Acting on a $2.5 million investment by CannaRoyalty and Trichome in 180 Smoke
Company Cassels Brock Role Golden Leaf Holdings Ltd. (GLH) Acted as Canadian counsel in connection with the acquisition of Chalice LLC (Chalice Farms) Canadian Securities Exchange listed company that is one of the largest cannabis oil and Acted on the acquisition of all of the shares of Medical Marihuana Group solution providers in North America Corporation, a licensed producer in St. Thomas, Ontario and Medical Marijuana Consulting Group Ltd. Acted on multiple financings, including brokered private placements of $35 million, $17.5 million, $15 million, $12 million, $5 million and $2.5 million RavenQuest BioMed Inc. (RQB) Acted on the acquisition of Bloomera, an Ontario-based licensed producer of cannabis under the ACMPR Canadian Securities Exchange listed company with divisions focused upon cannabis production, Acted as counsel on a $19.5 million and a $5 million private placement management services & consulting and specialized research & development Planet 13 Holdings Inc. (PLTH) Acted on its listing on the Canadian Securities Exchange, related subscription receipt financing and business combination Canadian Securities Exchange listed vertically integrated licensed cannabis company with operations in Las Vegas Vireo Health, Inc. Counsel on various corporate, securities and regulatory matters Private company that produces and distributes pharmaceutical-grade cannabis-derived medicines to patients Lift Co. Ltd. Counsel on various corporate, securities, regulatory, intellectual property and advertising matters Private company that operates Canada’s largest web platform to compare and review cannabis strains NanoLeaf Technologies Inc. Counsel on financing transactions and the acquisition of licensing rights to globally patented technologies that provide drug delivery formations Private biotech company possessing licensing rights to a number of globally patented technologies that developed and marketed the first cannabinoid standardized dose soft gel capsule in a nano-dispersed drug Resolve Digital Health Counsel on various trademark and intellectual property matters Private company which has a patented technology offering standardized dosing through single-use pods filled with cannabis oil Aphria Inc. (APH) Counsel to the agents on the $12.5 million subscription receipt financing that was completed in connection with Aphria Inc.’s qualifying transaction on the TSX listed company which is a licensed producer TSX Venture Exchange of medical cannabis in Canada Counsel to the underwriters on its $11.5 million short form prospectus offering Cronos Group Inc. (MJN) Counsel to the underwriters on multiple financings TSX Venture Exchange listed company which is a licensed producer of medical cannabis in Canada OrganiGram Holdings Inc. (OGI) Counsel to the underwriters on multiple financings, including brokered prospectus offerings of $115 million, $57.5 million, $40 million, $23 million and $10 million TSX Venture Exchange listed company which is a licensed producer of medical cannabis in Canada WeedMD Inc. (WMD) Counsel to the underwriters on multiple financings, including a $34.5 million bought deal equity financing, a $15 million brokered private placement of TSX Venture Exchange listed company which convertible unsecured debentures and a $7.5 million brokered private placement is a licensed producer and distributor of of convertible debentures and common share purchase warrants medical cannabis
Company Cassels Brock Role Indiva Limited (NDVA) Counsel to the underwriters on a $14.95 million public offering A TSX Venture Exchange listed company which is a federally-licensed producer of medical cannabis 48North Cannabis Corp. Counsel to the underwriters on a $16 million private placement A privately held ACMPR licensed producer of medical cannabis Namaste Technologies Inc. (N) Counsel to the underwriters on multiple financings Canadian Securities Exchange listed company which is an emerging leader in vaporizer and accessories space Khiron Life Sciences Corp. Counsel to the underwriters on an $11.23 million private placement A private Canadian integrated medical cannabis product development company with its core operations in Colombia Fire Cannabis Inc. d/b/a/ Slang Worldwide Acted as counsel to the agents on a $17.5 million private placement A private Canadian company focused on acquiring, developing and consolidating brands along the regulated supply chain in the global cannabis industry, including the US and developing distribution and supply chain opportunities Lifestyle Delivery Systems Inc. (LDS) Counsel to the agent on a private placement financing Canadian Securities Exchange listed vertically integrated cannabis related company in California, dealing with isogenics, cultivation, extraction, manufacturing and consulting EnWave Corporation (ENW) Counsel to the underwriters on multiple financings, including a $9.2 million public offering TSX Venture Exchange listed company with a patent application for very rapid and simultaneous pasteurization and drying of cannabis Cannabix Technologies Inc. (BLO) Acted as counsel to the underwriters on a $4.6 million private placement offering Canadian Securities Exchange listed company which is an emerging leader in cannabis breathalyser development Acreage Pharms Ltd. Acted on its acquisition by Invictus MD Strategies Corp. Private company that is a licensed producer of regulated medical cannabis CL2G Group Counsel on various corporate and transactional matters, including CL2G Group’s sale of cannabis services business to RavenQuest Biomed Inc. Private company that provides management and advisory services to Health Canada applicants Sunniva Inc. (SNN) Acted as counsel to the underwriters on a $27.8 million public offering Canadian Securities Exchange listed vertically integrated medical cannabis company with operations in Canada and the United States Santé Veritas Therapeutics Inc. Acting on its business combination with Baker Technologies, Inc., Briteside Holdings, LLC and Sea Hunter Therapeutics, LLC A private company committed to becoming a licensed producer under the ACMPR and Acted in its reverse take-over of Santé Veritas Holdings Inc. to thereafter operate as a medical cannabis cultivation company
Company Cassels Brock Role Dream Water Products Canada Inc. Acted in its acquisition by Harvest One Cannabis Inc. A private company that produces non- prescription flavored liquid sleep water that aids consumers to sleep naturally Investment Banking Clients in Cannabis Sector Beacon Securities Limited Canacord Genuity Corp. Clarus Securities Inc. Cormark Securities Inc. Eight Capital GMP Securities L.P. XIB Financial Inc. Brands and Talent in Cannabis Sector The Tragically Hip, among others Jurisdictions of International Deals and Clients in Cannabis Sector United States Colombia Jamaica Czech Republic Australia
Contact Information Key Contacts Financial Services LEONARD GLICKMAN, Co-Chair — Toronto JONATHAN FLEISHER, Partner — Toronto 416 869 5993 | lglickman@casselsbrock.com CHARLES (CHUCK) RICH, Partner — Toronto KENTON REIN, Partner — Calgary JONATHAN SHERMAN, Co-Chair — Toronto PETER J. SULLIVAN, Partner — Toronto 416 869 5409 | jsherman@casselsbrock.com DANIEL CIPOLLONE, Associate — Toronto Advocacy HILARY FENDER, Associate — Toronto MIKE TALLIM, Associate — Toronto TED FRANKEL, Partner — Toronto CARLY COHEN, Associate — Toronto Franchising & Retail Corporate, Securities and M&A FRANK ROBINSON, Partner — Toronto LARRY WEINBERG, Partner — Toronto ANDRÉ BOIVIN, Partner — Toronto JAKE BULLEN, Partner — Toronto Intellectual Property and Branding NANCY CHOI, Partner — Toronto SAM COLE, Partner — Vancouver CASEY CHISICK, Partner — Toronto JEFF DURNO, Partner — Vancouver ALISON HAYMAN, Partner — Toronto NICOLA GEARY, Partner — Toronto STEPHEN I. SELZNICK, Partner — Toronto JAY GOLDMAN, Partner — Toronto MARCO CIARLARIELLO, Associate — Toronto GREGORY HOGAN, Partner — Toronto A. CHANDIMAL NICHOLAS, Associate — Toronto SHAUN KHULLAR, Partner — Toronto Real Estate and Municipal EVAN LOW, Partner — Calgary SEAN MANIACI, Partner — Toronto ROBERT LYSY, Partner — Toronto CATHY L. MERCER, Partner — Toronto RAIVO UUKKIVI, Partner — Toronto CAMERON A. MINGAY, Partner — Toronto ARDY MOHAJER, Associate — Toronto JENNIFER TRAUB, Partner — Vancouver JOHN P. VETTESE, Partner — Toronto Regulatory ANN WATTERWORTH, Partner — Toronto CHRIS HERSH, Partner — Toronto XI CHEN, Associate — Toronto A. CHANDIMAL NICHOLAS, Associate — Toronto JAMIE LITCHEN, Associate — Toronto AMANDA METALLO, Associate — Toronto Technology and Licensing JACKSON PHILLIPS, Associate — Toronto BERNICE KARN, Partner — Toronto CHAD PODOLSKY, Associate — Toronto STEFANIE SEBANC, Associate — Toronto KYLE SIMPSON, Associate — Toronto Employment & Labour KRISTIN TAYLOR, Partner — Toronto © 2018 Cassels Brock & Blackwell LLP. All rights reserved. This document and the information in it is for illustration only and is subject Cassels Brock & Blackwell LLP to changes in the law and its interpretation. It does not constitute, and is not Toronto | Vancouver | Calgary a substitute for, legal or other professional advice. For advice on the matters discussed in this document, please consult legal counsel. casselsbrock.com
You can also read